Jazz Pharmaceuticals PLC Cash Flow Reinvestment Rate
Jazz Pharmaceuticals PLC cash flow reinvestment rate. Jazz Pharmaceuticals PLC (JAZZ) has a Cash Flow Reinvestment Rate of 0.59x as of March 2026, reinvesting $239.70 Million (capex $19.70 Million plus investments $220.00 Million) from operating cash flow of $408.20 Million. See Jazz Pharmaceuticals PLC free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Jazz Pharmaceuticals PLC (2010–2025)
Cash flow reinvestment rate of Jazz Pharmaceuticals PLC from 2010 to 2025. Historical reinvestment intensity for Jazz Pharmaceuticals PLC across 16 annual periods. Explore Jazz Pharmaceuticals PLC debt service capacity to assess how comfortably operating cash covers total debt obligations.
Jazz Pharmaceuticals PLC Cash Flow Reinvestment Rate by Year (2010–2025)
Jazz Pharmaceuticals PLC cash flow reinvestment rate by year from 2010 to 2025. Year-by-year capital reinvestment analysis for Jazz Pharmaceuticals PLC. For the full cash flow conversion analysis, see cash efficiency ratio of Jazz Pharmaceuticals PLC.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | $529.03 Million | $1.36 Billion | $58.75 Million | ▼ -2.1% |
| 2024 | 0.40x | $556.26 Million | $1.40 Billion | $48.07 Million | ▼ -29.0% |
| 2023 | 0.56x | $613.20 Million | $1.09 Billion | $23.96 Million | ▲ +43.1% |
| 2022 | 0.39x | $499.23 Million | $1.27 Billion | $498.19 Million | ▼ -72.6% |
| 2021 | 1.43x | $1.11 Billion | $778.51 Million | $45.53 Million | ▲ +25.9% |
| 2020 | 1.14x | $1.02 Billion | $899.65 Million | $379.25 Million | ▲ +161.2% |
| 2019 | 0.43x | $337.63 Million | $776.40 Million | $182.34 Million | ▼ -21.5% |
| 2018 | 0.55x | $442.38 Million | $798.90 Million | $131.47 Million | ▲ +42.7% |
| 2017 | 0.39x | $268.95 Million | $693.09 Million | $113.95 Million | ▼ -7.2% |
| 2016 | 0.42x | $246.86 Million | $590.54 Million | $181.58 Million | ▲ +119.7% |
| 2015 | 0.19x | $101.23 Million | $531.94 Million | $35.96 Million | ▼ -74.6% |
| 2014 | 0.75x | $304.25 Million | $405.76 Million | $238.97 Million | ▲ +177.8% |
| 2013 | 0.27x | $76.55 Million | $283.62 Million | $11.28 Million | ▼ -31.4% |
| 2012 | 0.39x | $98.27 Million | $249.75 Million | $22.48 Million | ▼ -26.9% |
| 2011 | 0.54x | $81.63 Million | $151.60 Million | $5.78 Million | ▲ +570.0% |
| 2010 | 0.08x | $4.73 Million | $58.87 Million | $4.73 Million | — |